Type 2 diabetes trials recruiting in District of Columbia

All Type 2 diabetes trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
  NCT06739122 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Diabetes Reversal Online Program and Study (DROP Study)
  NCT05572502 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• RESET System Pivotal Trial (Rev F)
  NCT04101669 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• The CARING Study: Creating and Restoring Health Through Nutrition Guidance
  NCT05795439 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
  NCT06730113 · Phase: Not specified · Ages: 12 Years to 25 Years · Sex: All (male and female) · District of Columbia: Washington D.C.